{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "May 2018: 58-year-old male presented with cough producing sputum mixed with blood at the First Affiliated Hospital of Nanchang University. Patient had a history of nephrolithiasis.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "58-year-old male presented with cough producing sputum mixed with blood",
              "onset": "May 2018",
              "associated_symptoms": [
                "C0010200",
                "C0038404"
              ]
            }
          ],
          "diagnoses": [
            {
              "code": "C0027717",
              "label": "Nephrolithiasis",
              "status": "historical"
            }
          ]
        },
        "timestamp": "2018-05"
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Computed tomography revealed primary lung cancer in the upper left lung with left hilar lymph node metastasis and multiple metastatic tumors in the liver (Fig1).",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "primary lung cancer in the upper left lung with left hilar lymph node metastasis and multiple metastatic tumors in the liver"
            }
          ],
          "diagnoses": [
            {
              "code": "C0024117",
              "label": "Lung Cancer",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C0027651",
              "label": "Metastasis",
              "status": "active",
              "onset_date": null
            }
          ]
        },
        "timestamp": "2018-05"
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Pathological examination of the bronchial biopsy revealed lung squamous cell carcinoma.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0007144",
              "label": "Squamous cell carcinoma of lung",
              "status": "active"
            }
          ],
          "procedures": [
            {
              "name": "C0006277",
              "approach": "endoscopic",
              "location": "Bronchial",
              "outcome": "biopsy"
            }
          ]
        },
        "timestamp": "2018-05"
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Cranial MRI and bone scan showed no significant abnormality. Diagnosed with stage IV lung squamous cell carcinoma. Next-generation sequencing (NGS) of lung cancer tissues showed no EGFR, ALK, ROS1, MET, BRAF V600E or NTRK gene mutation. Immunohistochemistry of lung cancer tissues showed PD-L1 tumor proportion score of 5%.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Magnetic resonance imaging of cranium",
              "body_part": "Cranium",
              "modality": "MRI",
              "finding": "no significant abnormality"
            },
            {
              "type": "Bone scan",
              "body_part": "Bone",
              "modality": "other",
              "finding": "no significant abnormality"
            }
          ],
          "diagnoses": [
            {
              "code": "C34",
              "label": "stage IV lung squamous cell carcinoma",
              "status": "active"
            }
          ],
          "labs": [
            {
              "test": "Next-generation sequencing",
              "value": "no EGFR, ALK, ROS1, MET, BRAF V600E or NTRK gene mutation",
              "unit": null,
              "flag": "normal"
            },
            {
              "test": "PD-L1 tumor proportion score",
              "value": "5%",
              "unit": "%",
              "flag": "normal"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "May 2018: Received first-line combined chemotherapy with four courses of gemcitabine and cisplatin. Progressive disease (PD) was found in the lung and liver lesions.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0017559",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2018-05",
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0008833",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2018-05",
              "end_date": null,
              "indication": null
            }
          ],
          "diagnoses": [
            {
              "code": "C0205864",
              "label": "Progressive disease",
              "status": "active",
              "onset_date": "2018-05"
            }
          ],
          "imaging": [
            {
              "type": "Lesion",
              "body_part": "C0024073",
              "modality": null,
              "finding": "Progressive disease",
              "impression": null,
              "date": "2018-05"
            },
            {
              "type": "Lesion",
              "body_part": "C0027051",
              "modality": null,
              "finding": "Progressive disease",
              "impression": null,
              "date": "2018-05"
            }
          ]
        },
        "timestamp": "2018-05"
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "August 2018: Docetaxel monotherapy was administered and he developed PD after two courses of chemotherapy.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Docetaxel",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2018-08",
              "end_date": null,
              "indication": null
            }
          ]
        },
        "timestamp": "2018-08"
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "October 2018: Third\u2010line targeted therapy with anlotinib (12\u2009mg once a day orally for two\u2009weeks",
        "reactions": "Grade 2 fatigue, Grade 1 oral mucositis, Grade 2 hand-foot syndrome, Grade 2 hypertriglycer",
        "clinical_data": {
          "medications": [
            {
              "drug": "anlotinib",
              "dosage": "12 mg",
              "frequency": "once a day",
              "modality": "oral",
              "start_date": "2018-10",
              "end_date": null,
              "indication": "Third-line targeted therapy"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient presented with cough and hemoptysis. CT scan revealed lung cancer with metastasis."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Bronchial biopsy performed to confirm diagnosis."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Further staging and molecular testing performed to guide treatment decisions."
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Initiation of first-line chemotherapy with gemcitabine and cisplatin.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0017559",
            "C0008833"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Disease progression on first-line chemotherapy.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C0205864"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Switch to docetaxel monotherapy, followed by disease progression and initiation of third-line targeted therapy with anlotinib.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "Docetaxel",
            "anlotinib"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    }
  ]
}